Home   >  
GPCR/G Protein
GnRH Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

GnRH Receptor

Chemical Structure Cat. No. Product Name CAS No.
Alarelin Acetate Chemical Structure
BCP27725 Alarelin Acetate 79561-22-1
Alarelin acetate is a synthetic GnRH agonist.
Histrelin Chemical Structure
BCP27657 Histrelin 76712-82-8
Histrelin is a nonapeptide analog of GnRH (gonadotropin-releasing hormone) with added potency. When present in the bloodstream, it can act on gonadotropes. Histrelin can stimulate these cells to release luteinizing hormone and follicle-stimulating hormone. Histrelin is considered a GnRH agonist. It can be used for the treatment of menstruation disorders.
Abarelix Chemical Structure
BCP27629 Abarelix 183552-38-7
Abarelix is a potent gonadotrophin-releasing hormone (GnRH) antagonist, used for prostate cancer treatment.
Linzagolix choline Chemical Structure
BCP30450 Linzagolix choline 1321816-57-2
Linzagolix choline is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist).
Linzagolix Chemical Structure
BCP30444 Linzagolix 935283-04-8
Linzagolix is a gonadotrophin releasing hormone (GnRH) antagonist.
Histrelin Acetate Chemical Structure
BCP19027 Histrelin Acetate 220810-26-4
Histrelin acetate is a nonapeptide analog of gonadotropin-releasing hormone (GnRH) with added potency.
Fertirelin acetate Chemical Structure
BCP19026 Fertirelin acetate 66002-66-2
Fertirelin Acetate is a gonadotropin-releasing hormone (GnRH) agonists that induces estrus in dogs and cats .
Nafarelin Acetate Chemical Structure
BCP19032 Nafarelin Acetate 86220-42-0
Nafarelin Acetate is the acetate salt form of nafarelin, a modified synthetic porcine luteinizing hormone (LH)-releasing hormone peptide analog, with gonadotropin-releasing hormone (GnRH) agonist activity.
Relugolix Chemical Structure
BCP21587 Relugolix 737789-87-6
Relugolix is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH)) antagonist, with potential antineoplastic activity.
Degarelix Chemical Structure
BCP20973 Degarelix 214766-78-6
Degarelix is a competitive gonadotropin-releasing hormone receptor (GnRHR) antagonist for the treatment of androgen-dependent advanced prostate cancer.
123下一页共 27 条记录 1 / 3 页